Skip to main content
Clinical Trials/NCT06200740
NCT06200740
Completed
Not Applicable

Remotely Observed Methadone Evaluation (ROME)

Sonara Health1 site in 1 country24 target enrollmentSeptember 25, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Opioid Use Disorder
Sponsor
Sonara Health
Enrollment
24
Locations
1
Primary Endpoint
System Usability Scale (SUS)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Opioid addiction, which affects 16 million individuals worldwide, can be treated using methadone, a proven and effective opioid medication for treating OUD that extends retention in care, reduces mortality, and inhibits illicit drug use. However, methadone treatment is limited to federally certified Opioid Treatment Programs (OTPs), which must meet complex regulatory requirements, and require new patients to take their dose in person six days per week, presenting significant barriers to treatment. To address these barriers, Sonara Heath has developed the Sonara software platform, which will enable OTPs to offer accelerated take-home methadone regimens while maintaining safety and diversion prevention.

Registry
clinicaltrials.gov
Start Date
September 25, 2022
End Date
December 2, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Sonara Health
Responsible Party
Principal Investigator
Principal Investigator

Michael Giles

Chief Executive Officer

Sonara Health

Eligibility Criteria

Inclusion Criteria

  • Receiving methadone for the treatment of opioid use disorder

Exclusion Criteria

  • Patients with \>13 take-homes
  • Patients with positive toxicology results in last 30-60 days
  • Patients involved with drug court ineligible for take-homes
  • Patients without adequate access to technology
  • Patients with \<30 days in treatment
  • Patients with mental health instability
  • Patients with recent diversion attempts
  • Patients using buprenorphine for agonist therapy
  • Patients guest dosing at another clinic during trial period

Outcomes

Primary Outcomes

System Usability Scale (SUS)

Time Frame: two weeks

The SUS, a 10-item scale with each item rated on a 5-point scale (scored 0 to 4) with five negative statements (e.g., system is unnecessarily complex) (reverse scored) and five positive statements (e.g., system functions are well integrated), evaluated user perceptions of the system's usability. We summed scores and multiplied them by 2.5 for the total score with a range from 0 to 100 (Lewis, 2018).

Secondary Outcomes

  • Acceptability, Appropriateness and Feasibility of Implementation Measures(two weeks)

Study Sites (1)

Loading locations...

Similar Trials